President Trump's executive order is giving psychedelic stocks a boost. These companies are leaders in the industry.

Surging interest in the purported benefits of psychedelic drugs has given rise to a new industry: psychedelic retreats.

Ibogaine is a plant-derived psychedelic medication that is illegal in the U.S. and many other countries. It causes hallucinations that can last more than 24 hours and cause cardiac problems. Studies show that ibogaine can be effective for short-term ...

The recent federal action directing the FDA to accelerate the review of psychedelic therapies marks a major shift in the development of next-generation mental health treatments. With regulatory timelines compressing and new federal support behind this category,

Add Yahoo as a preferred source to see more of our stories on Google. On a crisp November day in Aspen, Colorado, Rick Perry is stumping for iboga, a psychedelic shrub native to the Congo Basin rainforest in Central Africa known for producing powerful ...

President Donald Trump, on Saturday, instructed his administration to speed up reviews of psychedelic dr*gs, such as ibogaine, which has recently gained support among combat veterans and right-leaning lawmakers despite its significant safety concerns.